Work

Afatinib monotherapy in patients with metastatic squamous cell carcinoma of the lung progressing after erlotinib/gefitinib (E/G) and chemotherapy: Interim subset analysis from a phase III trial.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.7558

Authors: Joo-Hang Kim, Francesco Grossi, Filippo De Marinis, Manuel Cobo, James Chih-Hsin Yang, Yury Ragulin, Igor N. Bondarenko, Vikram K. Chand, Bushi Wang, Edith Gracien, Martin H. Schuler

Institutions: Yonsei University, Yonsei Cancer Hospital, Azienda Ospedaliera San Camillo-Forlanini, Hospital Regional Universitario de Málaga, National Taiwan University Hospital, Medical Radiological Research Center, Dnipro State Medical University, Boehringer Ingelheim (United States), Boehringer Ingelheim (Germany)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2957137166

Cites:

Cited by: 10

Related to: 10